Accumulating evidence has further indicated that HOTAIR has the capacity to activate autophagy [15], a cellular process capable of contributing to the pathogenesis of PD and thus, possibly representing a new molecular target for treating PD [16]. This evidence concerns the gene HOTAIR and Parkinson disease.